Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis

J Clin Microbiol. 2011 Jul;49(7):2743-7. doi: 10.1128/JCM.00127-11. Epub 2011 May 4.

Abstract

Scopulariopsis species are rarely but increasingly recognized as opportunistic pathogens in immunocompromised patients. We report on a patient suffering from cystic fibrosis who developed disseminated fungal infection due to a rare Scopulariopsis species, Microascus cirrosus, after heart and lung transplantation. Despite antifungal combination therapy with voriconazole and caspofungin, the patient died 4 weeks after transplantation. Diagnostic difficulties and optimal management of disseminated Scopulariopsis/Microascus infections are discussed.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / administration & dosage
  • Ascomycota / classification
  • Ascomycota / genetics
  • Ascomycota / isolation & purification*
  • Caspofungin
  • Cystic Fibrosis / complications*
  • DNA, Fungal / chemistry
  • DNA, Fungal / genetics
  • Echinocandins / administration & dosage
  • Fatal Outcome
  • Fungemia / diagnosis*
  • Fungemia / microbiology
  • Fungemia / mortality
  • Fungemia / pathology
  • Heart Transplantation / adverse effects*
  • Histocytochemistry
  • Humans
  • Immunocompromised Host
  • Lipopeptides
  • Lung Transplantation / adverse effects*
  • Male
  • Microscopy
  • Molecular Sequence Data
  • Mycoses / diagnosis*
  • Mycoses / microbiology
  • Mycoses / mortality
  • Mycoses / pathology
  • Pleura / pathology
  • Pyrimidines / administration & dosage
  • Radiography, Thoracic
  • Sequence Analysis, DNA
  • Tomography, X-Ray Computed
  • Triazoles / administration & dosage
  • Voriconazole

Substances

  • Antifungal Agents
  • DNA, Fungal
  • Echinocandins
  • Lipopeptides
  • Pyrimidines
  • Triazoles
  • Caspofungin
  • Voriconazole

Associated data

  • GENBANK/HQ676488